Troy Balderson Grills Top FDA Official On Inconsistent Goalposts For New Over-The-Counter Drugs

During a House Energy Committee hearing before the Congressional Recess, Rep. Troy Balderson (R-OH) asked Acting Director for Center for Drug Evaluation and Research at the FDA Dr. Jacqueline Corrigan-Curay about new over-the-counter drugs.<br />